ArticleMultiple sclerosis and related disorders2020

COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID.

Celsi Fiorella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.